Smruthi Organics Limited

SMRUTHIORG6

INE172E01011

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:00:56 21/05/2024 BST			5-day change	1st Jan Change
165.9 ^INR	-3.49%		-1.28%	-4.38%

05-06	Smruthi Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
02-03	Smruthi Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Smruthi Organics Limited Approves Dividend for the Year Ended 31 March 2023

August 05, 2023 at 12:47 pm

Smruthi Organics Limited announced that at its AGM held on 5 August 2023, the shareholders approved dividend of INR 2 per share (that is 20%) on 1,14,46,290 equity shares of INR 10 each for the year ended 31 March 2023.

Latest news about Smruthi Organics Limited

Smruthi Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-06	CI
Smruthi Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-03	CI
Smruthi Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-09	CI
Smruthi Organics Limited Approves Dividend for the Year Ended 31 March 2023	05/08/23	CI
Smruthi Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	05/08/23	CI
Smruthi Organics Limited Proposes Dividend for the Year Ended 31St March, 2023	12/07/23	CI
Smruthi Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	20/05/23	CI
Smruthi Organics Limited Announces Dividend for the Fiscal Year 2022-2023	20/05/23	CI
Smruthi Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	09/02/23	CI
Smruthi Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14/11/22	CI
Smruthi Organics Limited Approves the Dividend for the Year Ended March 31, 2022	08/08/22	CI
Smruthi Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	06/08/22	CI
Smruthi Organics Limited Recommends Dividend	28/05/22	CI
Smruthi Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	28/05/22	CI
Smruthi Organics Limited Approves Board Changes	12/02/22	CI
Smruthi Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	12/02/22	CI
Smruthi Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	13/11/21	CI
Smruthi Organics' : Net Profit Slides in Fiscal Q1	16/07/21	MT
Smruthi Organics Limited Declares Dividend for the Year Ended 31 March 2021	16/07/21	CI
Smruthi Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	16/07/21	CI
Smruthi Organics Limited Recommends Dividend, Payable on or Before August 14, 2021	09/06/21	CI
Smruthi Organics Limited Recommends Dividend for the Year Ended March 31, 2021	23/04/21	CI
Smruthi Organics Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	23/04/21	CI
Smruthi Organics Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	16/01/21	CI
Smruthi Organics Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	19/10/20	CI

Chart Smruthi Organics Limited

Duration

Period

More charts

Company Profile

Smruthi Organics Limited is an India-based active pharmaceutical ingredients (API) manufacturer serving pharmaceutical companies. The Companyâs segments include Bulk Drugs and Drugs Intermediates and Formulation. It manufactures API products in the anti-diabetic, anti-hypertension and anti-infectives therapeutic categories. Its products include Amlodipine Besilate, Losartan Potassium, Telmisartan, Metformin HCL, S-Amlodipine Besilate, S-Amlodipine Malelate, Valsartan, Vildagliptin, Teneligliptin, Ciprofloxacin HCL, Diloxanide Furoate, Norfloxacin, Pefloxacin Mesylate, Ticagrelor, and others. It caters to both the Indian domestic as well as the rest of the world (ROW) markets, with clients spanning Asia, the Americas, and Africa. The Company has two manufacturing facilities in Solapur, India. The API facility is spread across 22-acre land.

Sector

Pharmaceuticals

Calendar

07/11/2024 - Q2 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SMRUTHI ORGANICS LIMITED	-4.38%	23.62M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+22.35%	44.12B
OTSUKA HOLDINGS CO., LTD.	+22.22%	22.61B
SANDOZ GROUP AG	+17.81%	15.11B
CIPLA LIMITED	+15.73%	13.61B
ZYDUS LIFESCIENCES LIMITED	+57.91%	13.34B
ONO PHARMACEUTICAL CO., LTD.	-8.98%	6.94B
THE MEDICINES COMPANY	-0.05%	6.79B
ASPEN PHARMACARE HOLDINGS LIMITED	+15.65%	5.75B
STADA ARZNEIMITTEL	-8.87%	5.73B